New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report).
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005227:Fatty Acids / Q000627:therapeutic use; D006801:Humans; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D051379:Mice; D010938:Plant Oils / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014315:Triterpenes / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005227:Fatty Acids; D010938:Plant Oils; D014315:Triterpenes; C004555:hydnocarpic acid; D003622:Dapsone; D002991:Clofazimine; C004446:asiaticoside; D012293:Rifampin